Delivery Order HHSN272201600008I-HHSN27200002
Award Date
8/25/16
Potential Completion Date
9/27/23
Potential Value
$174K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN81 - R&D- Medical: Aids Research (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $572,349.48, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract is for material receipt, storage, shipping, and inventory services to support NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. This is a Delivery Order under ABL's existing...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Advanced Bioscience Laboratories, Inc. (ABL), a contract research and manufacturing organization. The $3,150,428.64 award is a delivery order under the HIV Microbicides and Biomedical Prevention 2016-2021 indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. ABL will provide comprehensive resources for HIV...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Advanced Bioscience Laboratories, Inc. (ABL). The contract, valued at $239,850.00, is a Delivery Order issued under the HIV Microbicides and Biomedical Prevention 2016-2021 master IDIQ vehicle. ABL, a contract research and manufacturing organization, will assist NIAID in planning and implementing two meetings...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $1,529,440.80 cost-plus-fixed-fee contract provides statistical support for HIV non-vaccine biomedical prevention product development under NIAID's "Comprehensive Resources for HIV Microbicides and Biomedical Prevention"...
This federal contract award, valued at $844,713.24, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is for support in enhancing study drug adherence in HIV prevention trials, falling under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical Prevention program. The contract is a cost-plus-fixed-fee delivery order under the...
This federal contract award, valued at $1,278,579.71, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The contract supports statistical and pharmacometric modeling for the development of HIV non-vaccine biomedical prevention products under NIAID's Comprehensive Resources for HIV Microbicides and Biomedical...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Advanced Bioscience Laboratories, Inc. (ABL). The $9,967,500.00 cost-plus-fixed-fee contract supports NIAID's Preclinical Development program, specifically the production of the MHRP GP145 Clade C trimer protein. This contract does not have a set-aside designation. ABL, a for-profit manufacturer of goods, has been...
This is a federal contract award to Advanced Bioscience Laboratories, Inc. (ABL) by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), a civilian federal agency. The contract, valued at $4,328,663.00, is for expertise in the product development lifecycle, including services such as cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and project management for infectious...
This federal contract award is to Advanced Bioscience Laboratories, Inc. (ABL) from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The contract is for the performance of toxicity testing for HIV proteins as part of NIAID's Preclinical Development Support program. The contract is a cost-plus-fixed-fee delivery order with a ceiling value of $1,050,558.51 and a period of performance through April 7, 2017....
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Advanced Bioscience Laboratories, Inc. (ABL), a for-profit manufacturer of goods. The $795,403.00 contract is a delivery order awarded under an existing Indefinite Delivery Vehicle (IDV) for "Advanced Bioscience Laboratories Mucosal Vaccine Technologies". The contract is cost-plus-fixed-fee in type...